Cargando…
High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
Diabetes is a major risk factor in the development and progression of several cancers including cholangiocarcinoma (CCA). However, the molecular mechanism by which hyperglycemia potentiates progression of CCA is not clearly understood. Here, we showed that a high glucose condition significantly incr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780024/ https://www.ncbi.nlm.nih.gov/pubmed/33141432 http://dx.doi.org/10.1111/cas.14719 |
_version_ | 1783631435259707392 |
---|---|
author | Thonsri, Unchalee Wongkham, Sopit Wongkham, Chaisiri Hino, Shinjiro Nakao, Mitsuyoshi Roytrakul, Sittiruk Koga, Tomoaki Seubwai, Wunchana |
author_facet | Thonsri, Unchalee Wongkham, Sopit Wongkham, Chaisiri Hino, Shinjiro Nakao, Mitsuyoshi Roytrakul, Sittiruk Koga, Tomoaki Seubwai, Wunchana |
author_sort | Thonsri, Unchalee |
collection | PubMed |
description | Diabetes is a major risk factor in the development and progression of several cancers including cholangiocarcinoma (CCA). However, the molecular mechanism by which hyperglycemia potentiates progression of CCA is not clearly understood. Here, we showed that a high glucose condition significantly increased reactive oxygen species (ROS) production and promoted aggressive phenotypes of CCA cells, including proliferation and migration activities. Mannosidase alpha class 2a member 2 (MAN2A2), was upregulated at both mRNA and protein levels in a high glucose‐ and ROS‐dependent manner. In addition, cell proliferation and migration were significantly reduced by MAN2A2 knockdown. Based on our proteome and in silico analyses, we further found that chromodomain helicase DNA‐binding protein 8 (CHD8) was induced by ROS signaling and regulated MAN2A2 expression. Overexpression of CHD8 increased MAN2A2 expression, while CHD8 knockdown dramatically reduced proliferation and migration as well as MAN2A2 expression in CCA cells. Moreover, both MAN2A2 and CHD8 were highly expressed with positive correlation in CCA tumor tissues. Collectively, these data suggested that high glucose conditions promote CCA progression through ROS‐mediated upregulation of MAN2A2 and CHD8. Thus, glucose metabolism is a promising therapeutic target to control tumor progression in patients with CCA and diabetes. |
format | Online Article Text |
id | pubmed-7780024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77800242021-01-08 High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 Thonsri, Unchalee Wongkham, Sopit Wongkham, Chaisiri Hino, Shinjiro Nakao, Mitsuyoshi Roytrakul, Sittiruk Koga, Tomoaki Seubwai, Wunchana Cancer Sci Cell, Molecular, and Stem Cell Biology Diabetes is a major risk factor in the development and progression of several cancers including cholangiocarcinoma (CCA). However, the molecular mechanism by which hyperglycemia potentiates progression of CCA is not clearly understood. Here, we showed that a high glucose condition significantly increased reactive oxygen species (ROS) production and promoted aggressive phenotypes of CCA cells, including proliferation and migration activities. Mannosidase alpha class 2a member 2 (MAN2A2), was upregulated at both mRNA and protein levels in a high glucose‐ and ROS‐dependent manner. In addition, cell proliferation and migration were significantly reduced by MAN2A2 knockdown. Based on our proteome and in silico analyses, we further found that chromodomain helicase DNA‐binding protein 8 (CHD8) was induced by ROS signaling and regulated MAN2A2 expression. Overexpression of CHD8 increased MAN2A2 expression, while CHD8 knockdown dramatically reduced proliferation and migration as well as MAN2A2 expression in CCA cells. Moreover, both MAN2A2 and CHD8 were highly expressed with positive correlation in CCA tumor tissues. Collectively, these data suggested that high glucose conditions promote CCA progression through ROS‐mediated upregulation of MAN2A2 and CHD8. Thus, glucose metabolism is a promising therapeutic target to control tumor progression in patients with CCA and diabetes. John Wiley and Sons Inc. 2020-11-29 2021-01 /pmc/articles/PMC7780024/ /pubmed/33141432 http://dx.doi.org/10.1111/cas.14719 Text en © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Cell, Molecular, and Stem Cell Biology Thonsri, Unchalee Wongkham, Sopit Wongkham, Chaisiri Hino, Shinjiro Nakao, Mitsuyoshi Roytrakul, Sittiruk Koga, Tomoaki Seubwai, Wunchana High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title | High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title_full | High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title_fullStr | High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title_full_unstemmed | High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title_short | High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 |
title_sort | high glucose‐ros conditions enhance the progression in cholangiocarcinoma via upregulation of man2a2 and chd8 |
topic | Cell, Molecular, and Stem Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780024/ https://www.ncbi.nlm.nih.gov/pubmed/33141432 http://dx.doi.org/10.1111/cas.14719 |
work_keys_str_mv | AT thonsriunchalee highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT wongkhamsopit highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT wongkhamchaisiri highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT hinoshinjiro highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT nakaomitsuyoshi highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT roytrakulsittiruk highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT kogatomoaki highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 AT seubwaiwunchana highglucoserosconditionsenhancetheprogressionincholangiocarcinomaviaupregulationofman2a2andchd8 |